Coronavirus infections broke records in parts of Europe on November 24, with the continent once again the epicenter of a pandemic that has prompted new curbs on movement and made health experts think again about booster vaccination shots.
If you are not happy with the results below please do another search
50 search results for:
Shares of Kura Oncology plunged in trading on November 24 after the San Diego-based company announced the U.S. Food and Drug Administration placed a partial clinical hold on a Phase Ib leukemia study assessing KO-539 following the report of a patient’s death.
A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides.
The World Health Organization (WHO) reported its projections for the 53 countries in Europe to have another 700,000 deaths from Covid-19 by spring 2022, which would bring the total to more than 2 million in the region.
Top U.S. infectious disease official Dr. Anthony Fauci said on November 23 the vast majority of Americans who have been vaccinated against Covid-19 should receive a booster shot, and that an additional dose could eventually become the country’s standard for determining who is fully vaccinated.
A federal jury on November 23 found that pharmacy chain operators CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. helped fuel an opioid epidemic in two Ohio counties, in the first trial the companies have faced over the U.S. drug crisis.
The Biden administration asked a federal appeals court on November 23 to lift a court-ordered stay on a sweeping workplace Covid-19 vaccine rule to avoid serious harm to public health, or alternatively to allow a masking-and-testing requirement.
The U.S. Food and Drug Administration approved Takeda Pharmaceutical Co. Ltd.’s drug Livtencity for a common type of viral infection occurring in patients after organ transplant.
The World Health Organization said on November 23 an additional 700,000 people could die from Covid-19 in Europe by March 2022, taking the total to above 2.2 million, as the WHO urged people to get vaccinated and to have booster shots.
The Food and Drug Administration cleared the way for Tonix Pharmaceuticals to begin a Phase II study of the company’s therapeutic candidate, which intends to prevent migraine headaches.